Gili Regev-Yochay, MD
Director of Infectious Disease Epidemiology Unit

Academic Clinical Experience:

7-9/1991           Elective training in rural hospital (Elim) in Gazankulu, S. Africa

1993-94            Internship Year Sheba medical center, Tel-Hashomer, Israel

7-12/1994         Volunteering doctor in Leh district hospital, Ladakh, India

1/95-6/98          Resident doctor in Internal Medicine, Dep. A,

                       Sheba medical center, Tel-Hashomer, Israel

11/98-12/2000   Resident in the Infectious Diseases Unit,

           Sheba medical center, Tel-Hashomer, Israel

1/2001-8/2004    An Infectious disease specialist

                       Sheba medical center, Tel-Hashomer, Israel (Prof. E Rubinstein)

3/2001-8/2004   Primary care physician in an Ethiopian immigrant center clinic

                       of Maccabi Healthcare Services, Mevaseret-Zion, Israel.

9/2004- 6/2007  Post-Fellowship in Infectious Disease Epidemiology &

                        Immunology. Harvard School of Public Health, Boston, MA. USA

7/2007-7/2008   Post-Fellowship in Infectious disease research lab.

                       Children's Hospital Boston, MA. USA.

9/2008-present  Senior physician and Head of ID epidemiology research lab,

                        Infectious Disease Unit, Sheba Medical Center, Tel-Hashomer,


9/2008-5/2011   Senior researcher at the Gertner Institute for Epidemiology

                        Research, Tel-Hashomer, Israel.

6/2011-Present  Head of Section of Infectious Disease Epidemiology, the

                        Gertner Institute for Epidemiology Research, Tel-Hashomer,




Education and Degrees

01/1990      MSc. at Neurobiology dept. of Weizmann Institute of Science.

      Rehovot, Israel.

12/1994      MD. at Ben-Gurion university, Soroka medical center, Beer-Sheva, Israel.

MD. Thesis: The effect of neurotensinogenic ligands on place navigation learning.

06/2006      MS in Epidemiology at the Harvard School of Public Health,    

                  Boston, MA. USA. (Infectious Disease and Immunology



Academic Degrees:

Visiting Lecturer at the Tel-Aviv University, Sackler school of Medicine.2008-2011

Senior Lecturer (equiv. Assistant Professor) at the Tel-Aviv University, Sackler

school of Medicine, 2011 To date.

Instructor at the Harvard School of Public Health since Jan. 2007





  • Infectious Diseases
  • Epidemiology
  • Public Health
  • Antibiotic Resistance
  • Vaccination effects







1.     G. Regev-Yochay, G. Rahav, M. Katzir, K. Reisenberg, J. Bishara, Y. Wiener-Well, M. stein, G. Weber, D. Glikman, R. Dagan for the IAIPD study group. Initial effects of the National PCV7 childhood immunization Program on Adult Invasive Pneumococcal Disease in Israel. Vaccine 2013 Mar 19. [Epub ahead of print]).

2.     A Biber, I Abuelaish, G Rahav, M Raz, L Cohen, L Valinsky, D Taran, A Goral, A Elhamdany and G Regev-Yochay for the PICR study group.  A Typical Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clone is Widespread in the Community in the Gaza Strip. PLoS One 2012; 7(8):e42864. Epub 2012 Aug 16.

3.     G. Regev-Yochay, I Abullaish, R. Malley, B. Shainberg, M. Varon, Y. Roytman, A. Ziv, A. Goral, A. Elhamdany, G. Rahav and Meir Raz for the Palestinian-Israeli Collaborative Research (PICR) study group. S. pneumoniae carriage in the Gaza strip. PLoS One 2012. Apr 23.

4.     E. Leshem, A Maayan-Metzger , G Rahav, M Dolitzki, J Kuint, Y Roytman, A Goral, I Novikov,  R Fluss, N Keller and  G Regev-Yochay. Transmission of Staphylococcus aureus from Mothers to Newborns. Pediat Infect Dis J 2012 Apr. 31; 360-363.

5.     E. Mostofsky, M. Lipsitch and G. Regev-Yochay.  Is Methicillin-Resistant Staphylococcus aureus Replacing Methicillin-Susceptible S. aureus? J Antimicrobials and Chemotherapy. 2011 Oct;66(10):2199-214

6.     G. Regev-Yochay, M. Raz, R. Dagan, H. Roizin, B. Morag, S. Hetman, S. Ringel, N. Ben-Israel, M. Varon, E. Somekh, E. Rubinstein. Reduction in Antibiotic use following a cluster randomized controlled multifaceted intervention; The Israeli Judicious antibiotic prescription (IJAP) study. Clin Infect Dis 2011 Jul;53(1):33-41.

7.     Y. Maor, M. Raz, E. Rubinstein, E. Derazne, S. Ringel, G. Rahav and G. Regev-Yochay. Changing Parents' Opinions Regarding Antibiotic Use in Primary Care. Eur J Pediatrics. 2011 Mar 170(3):359-64.

8.     G. Regev-Yochay, WP Hanage, K Trzcinski, SL Rifas-Shiman, G Lee, A Bessolo, SH Huang, SI Pelton, JA Finkelstein, M. Lipstich and R. Malley. Re-emergence of the Type 1 Pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine 2010 Jul 5;28(30):4842-6

9.     D. Ben-David, Y. Maor, N. Keller, G. Regev-Yochay, I. Tal, D. Shachar, A. Zlotkin, G. Smollan and G. Rahav.  Control of a Hospital-wide Outbreak of Carbapenem-resistant Klebsiella pneumoniae and the Role of Active Surveillance. Infection Control and Hospital Epidemiology. 2010. Jun; 31(6):620-6..

10.  G. Regev-Yochay, M. Raz, Y. Carmeli, B. Shainberg, S. Navon-Venezia, E. Pinco, A. Leavitt, N. Keller, G. Rahav , Richard Malley and E. Rubinstein    for the Maccabi IJAP Study Group. Parental Staphylococcus aureus-carriage is a major risk factor for staphylococcal carriage in young children. Pediat Infect Dis J Dec. 2009. Sep 4. [Epub]

11.  L. Selva, D. Viana, G. Regev-Yochay, K. Trzcinski, J. M. Corpa, D. Lasa, R. Novick and J. Penades. Killing Niche Competitors by Remote-Control Phage Induction. P Natl Acad Sci USA 2009. Jan 27;106(4):1234-8.

12.  D.M. Weinberger, R. Dagan, N. Givon-Lavi, G. Regev-Yochay, R. Malley and M. Lipsitch. Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J Infect. Dis. 2008. June1; 197(11):1511-8

13.  I. Chmelnitsky, S. Navon-Venezia, A. Leavit, E. Somekh, G. Regev-Yochay, M. Chowers, P. Shitrit and Y. Carmeli. SCCmec and spa types of methicilllin-resistant Staphylococcus aureus strains in Israel. Dectection of SCCmec type V. Eur J. Clin Microbiol Infec Dis. 2008 May;27(5):385-90

14.  G. Regev-Yochay, R. Malley, E. Rubinstein, M. Raz, R. Dagan and M. Lipsitch. In vitro bactericidal activity of Streptococcus pneumoniae and susceptibility of Staphylococcus aureus strains isolated from co-colonized vs. non-co-colonized children. J Clinic Microbiol. Nov. 26, 2007. Epub.

15.  G. Regev-Yochay, M. Lipsitch, K. Trzcinski, C. M. Thompson and R. Malley. SpxB is a pneumococcal suicide gene and confers a selective advantage in colonization. J. Bacteriology. 2007; Sept 189(18); 6532-9.

16.  G. Regev-Yochay, Y. Carmeli, M. Raz, E. Pinco, J. Etienne, A. Leavitt, E. Rubinstein and S. Navon-Venzia. Prevalence and Genetic Relatedness of Community-Acquired Methicillin-Resistant Staphylococcus aureus in Israel. European J Clinic Microbiol & Infect Dis. 2006; Nov, 25(11); 719-22.

17.  G. Regev-Yochay, K. Trzcinski, C. M. Thompson, R. Malley, M. Lipsitch. Interference between S. pneumoniae and S. aureus; in vitro hydrogen peroxide mediated killing by S. pneumoniae. J. Bacteriology. 2006; 188: 4996-5001.

18.  R. Dagan, G. Regev-Yochay, E. Rubinstein. Resistant organisms and otitis media. Pediatr Infect Dis J. 2005;24:849.

19.  M. Weinberger, L. Leibovici, S. Perez, Z. Samra, I. Ostfeld, I. Levi, E. Bash, D. Turner, A. Goldschmied-Reouven, G. Regev-Yochay, S.D. Pitlik and N. Keller. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect. 2005; 61:146-54.

20.  G. Regev-Yochay, E. Rubinstein, A. Barzilai, Y. Carmeli, J. Kuint, J. Etienne, M. Blech, G. Smollen, A. Maayan-Metzger, A. Leavitt, G. Rahav and N. Keller. A Nosocomial Outbreak of a suspected Community-associated-Methicillin-Resistant Staphylococcus aureus strain in a Neonatal Intensive Care Unit. Emerg Infect Dis. 2005; 11: 453-456.

21.  G. Regev-Yochay, R. Dagan, M. Raz, Y. Carmeli, B. Sheinberg, E. Derazne, G. Rahav, and E. Rubinstein. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA. 2004; 292: 716-720.